Jazz Pharmaceuticals announced that Samantha Pearce, SVP, Europe and International, has been promoted to Chief Commercial Officer effective August 1, 2024. Pearce joined Jazz as SVP, Europe and International, in 2020. From March 2010 to December 2019, Pearce held general management positions with Celgene, most recently as vice president and general manager of international markets. Prior to that, from August 2002 to March 2010, she served in commercial management positions at AstraZeneca, culminating in her role as director of specialist care. Prior to August 2002, she worked for DuPont Pharmaceuticals.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JAZZ:
- Jazz Pharmaceuticals price target lowered to $113 from $117 at UBS
- Jazz Pharmaceuticals’ Phase 2b trial in essential tremor doesn’t meet endpoints
- Biotech Alert: Searches spiking for these stocks today
- ‘Load Up,’ Says Goldman Sachs About These 2 Strong Buy Stocks
- Instacart, Boston Beer upgraded: Wall Street’s top analyst calls